Page last updated: 2024-08-26

obovatol and Bone Loss, Osteoclastic

obovatol has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, JY; Hong, JM; Kim, HJ; Kim, SY; Kwon, BM; Lee, IK; Yoon, HJ	1

Other Studies

1 other study(ies) available for obovatol and Bone Loss, Osteoclastic

Article	Year
Inhibitory effects of obovatol on osteoclast differentiation and bone resorption. European journal of pharmacology, 2014, Jan-15, Volume: 723 Topics: Animals; Biphenyl Compounds; Bone Density; Bone Density Conservation Agents; Bone Resorption; Caspase 3; Cell Differentiation; Femur; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Phenyl Ethers; Proto-Oncogene Proteins c-fos; Radiography; RANK Ligand	2014

Article

Year

Inhibitory effects of obovatol on osteoclast differentiation and bone resorption.

European journal of pharmacology, 2014, Jan-15, Volume: 723

Topics: Animals; Biphenyl Compounds; Bone Density; Bone Density Conservation Agents; Bone Resorption; Caspase 3; Cell Differentiation; Femur; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Phenyl Ethers; Proto-Oncogene Proteins c-fos; Radiography; RANK Ligand

2014